Showing results (771-780 of 1,482) with videos related to
Sort By:
Pageof 149
Human Psychopharmacology|May 27, 2015
Explaining pharmacophobia and pharmacophilia in psychiatric patients: relationship with treatment adherenceCarlos De Las Cuevas, Wenceslao PeñateHuman Psychopharmacology|May 1, 2020
Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controlsZhaohua Zhang, Minling Zhang, Yayan Luo, et al.Human Psychopharmacology|August 21, 2021
Response efficacy and heterogeneity of antipsychotic drugs in schizophrenia: Systemic review and meta-analysisXin Zhang, Jia Tang, Xue Zhang, et al.Human Psychopharmacology|August 19, 2022
Facilitated extinction of conditioned fear responses by delta 9-tetrahyrdrocannabidol in humans: a pilot studyHerman A Diggs, Norka E Rabinovich, David G GilbertHuman Psychopharmacology|February 5, 2005
Towards consensus in the long-term management of relapse prevention in schizophreniaM Taylor, I Chaudhry, M Cross, et al.Human Psychopharmacology|March 3, 2004
Maintenance treatment for schizophrenia with quetiapinePeter F BuckleyHuman Psychopharmacology|August 11, 2004
Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to ageShigeru Morishita, Seizaburo AritaHuman Psychopharmacology|June 8, 2004
Drug utilization review of risperidone for outpatients in a tertiary referral hospital in SingaporeNan Luo, Yvonne Koh, Chay Hoon Tan, et al.Human Psychopharmacology|July 15, 2004
Subjective and polysomnographic effects of milnacipran on sleep in depressed patientsPatrick Lemoine, Thierry FaivreHuman Psychopharmacology|July 15, 2004
Effects of modafinil on cognitive and meta-cognitive performanceJoseph V Baranski, Ross Pigeau, Peter Dinich, et al.Pageof 149